Quest Laboratories (NSE:QUESTLAB) Capital Expenditure: ₹-44.14 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:QUESTLAB Quest Laboratories Ltd NSE:QUESTLAB
46 GF Score
Price ₹84.70
! 5 Warning Signs
View Full Analysis

What is Quest Laboratories Capital Expenditure?

Quest Laboratories NSE:QUESTLAB +0.89% 46 Capital Expenditure is ₹-44.14 Mil as of Mar. 2026. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 46/100. The stock has 5 warning signs investors should review.

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Quest Laboratories's cash flow for capital expenditures for the three months ended in Mar. 2026 was ₹0 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-44.14 Mil.

Quest Laboratories Capital Expenditure Historical Data

* Premium members only.

The historical data trend for Quest Laboratories's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Laboratories Capital Expenditure Chart

Quest Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Capital Expenditure
Get a 7-Day Free Trial -19.31 -30.14 -9.40 -34.71 -52.50

Quest Laboratories Quarterly Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Capital Expenditure Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 -44.14 0.00
NSE:QUESTLAB
46GF Score
Quest Laboratories Ltd NSE:QUESTLAB
Capital Expenditure is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quest Laboratories Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-44.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Capital Expenditure →
What does a Capital Expenditure of ₹-44.14 Mil mean?
Quest Laboratories (NSE:QUESTLAB) has a Capital Expenditure of ₹-44.14 Mil as of Mar. 2026. Capital Expenditures represent the company's purchases of property, plant, equipment and other long-term fixed assets. View historical data for Quest Laboratories.
Is Quest Laboratories' Capital Expenditure too high?
Quest Laboratories' current Capital Expenditure is ₹-44.14 Mil. Overall, Quest Laboratories has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' Capital Expenditure compare to LLY and JNJ?
Quest Laboratories' Capital Expenditure of ₹-44.14 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capital Expenditure for a Drug Manufacturers company?
A good Capital Expenditure depends on the Drug Manufacturers industry context. However, Capital Expenditure should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capital Expenditure mean?
A high Capital Expenditure can signal that a stock is expensive relative to its fundamentals. Capital Expenditures represent the company's purchases of property, plant, equipment and other long-term fixed assets. View historical data for Quest Laboratories. Quest Laboratories's current Capital Expenditure is ₹-44.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current Capital Expenditure of ₹-44.14 Mil. The current Capital Expenditure is ₹-44.14 Mil. Quest Laboratories' overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capital Expenditure calculated?
Capital Expenditure is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current Capital Expenditure is ₹-44.14 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest Laboratories Business Description

Address Sector III, Plot No. 45, Pithampur Industrial Area, Opposite Kissan Pipe Unit 4, District Dhar, Pithampur, Dhar, MP, IND, 454775
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
46GF Score

Get the complete analysis for NSE:QUESTLAB

Capital Expenditure is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹84.70
Price